Progyny, Inc.

PGNY

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
PGNY
CIK0001551306
SIC8090
SectorServices
Industry CategoryHealthcare
Industry GroupServices – Health

Contact

Address1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Website progyny.com
Phone212-888-3124
CEOPeter Anevski
Employees310

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$1.21 billion
Pre-Tax Income$87.22 million
Net Income$52.50 million
Net Income to Common$52.50 million
EPS$0.57
View All
Balance Sheet
Cash$109.24 million
Assets$730.28 million
Liabilities$263.13 million
Common Equity$467.16 million
Liabilities & Equity$730.28 million
View All
Cash Flow Statement
Calculations
NOPAT$44.00 million
EBITDA$90.79 million
Price to Earnings$36.41
Price to Book$4.09
ROE10.11%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

There May Be Reason For Hope In Progyny's (NASDAQ:PGNY) Disappointing Earnings

The most recent earnings report from Progyny, Inc. ( NASDAQ:PGNY ) was disappointing for shareholders. Despite the soft...

Article Link

3 Cash-Producing Stocks in the Doghouse

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Article Link

Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board

Medical Advisory Board additions support company’s growing product offerings across women’s health and family building NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Inferti

Article Link

What Is Progyny, Inc.'s (NASDAQ:PGNY) Share Price Doing?

Progyny, Inc. ( NASDAQ:PGNY ), is not the largest company out there, but it received a lot of attention from a...

Article Link

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations

Article Link